Walleye Capital’s Perspective Therapeutics CATX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $645K | Buy |
187,403
+148,013
| +376% | +$509K | ﹤0.01% | 982 |
|
|
2025
Q1 | $83.9K | Sell |
39,390
-436,402
| -92% | -$930K | ﹤0.01% | 1564 |
|
|
2024
Q4 | $1.52M | Buy |
475,792
+457,675
| +2,526% | +$1.46M | ﹤0.01% | 802 |
|
|
2024
Q3 | $242K | Sell |
18,117
-494,706
| -96% | -$6.6M | ﹤0.01% | 1605 |
|
|
2024
Q2 | $5.11M | Buy |
+512,823
| New | +$5.11M | 0.01% | 463 |
|
|
2021
Q2 | – | Sell |
-2,423
| Closed | -$26 | – | 1333 |
|
|
2021
Q1 | $26 | Buy |
+2,423
| New | +$26 | ﹤0.01% | 1100 |
|